Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New-onset focal epilepsy with palatal tremor and glutamic acid decarboxylase antibodies responding to intravenous immunoglobulin.

Literature DB >> 18758886

New-onset focal epilepsy with palatal tremor and glutamic acid decarboxylase antibodies responding to intravenous immunoglobulin.

Michael Marnane, Aangela Vincent, Michael Hutchinson.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2008 PMID： 18758886 DOI： 10.1007/s00415-008-0986-4

Source DB: PubMed Journal: J Neurol ISSN： 0340-5354 Impact factor: 4.849

× No keyword cloud information.

14 in total

1. Encephalitis associated with glutamic acid decarboxylase autoantibodies.

Authors: G C Marchiori; A Vaglia; M Vianello; P G Bardin; B Giometto
Journal: Neurology Date: 2001-03-27 Impact factor: 9.910

2. Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.

Authors: S Vulliemoz; G Vanini; A Truffert; C Chizzolini; M Seeck
Journal: J Neurol Neurosurg Psychiatry Date: 2007-02 Impact factor: 10.154

3. Antibodies to voltage-gated potassium and calcium channels in epilepsy.

Authors: H J Marian Majoie; Mark de Baets; Willy Renier; Bethan Lang; Angela Vincent
Journal: Epilepsy Res Date: 2006-07-25 Impact factor: 3.045

4. Temporal-lobe epilepsy associated with glutamic-acid-decarboxylase autoantibodies.

Authors: B Giometto; P Nicolao; M Macucci; B Tavolato; R Foxon; G F Bottazzo
Journal: Lancet Date: 1998-08-08 Impact factor: 79.321

5. The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies.

Authors: Marinos C Dalakas
Journal: J Neurol Date: 2005-05 Impact factor: 4.849

6. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase.

Authors: S Baekkeskov; H J Aanstoot; S Christgau; A Reetz; M Solimena; M Cascalho; F Folli; H Richter-Olesen; P De Camilli; P D Camilli
Journal: Nature Date: 1990-09-13 Impact factor: 49.962

7. Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy.

Authors: J Peltola; P Kulmala; J Isojärvi; A Saiz; K Latvala; J Palmio; K Savola; M Knip; T Keränen; F Graus
Journal: Neurology Date: 2000-07-12 Impact factor: 9.910

8. Autoantibodies to glutamic acid decarboxylase in downbeat nystagmus.

Authors: G Antonini; R Nemni; F Giubilei; F Gragnani; V Ceschin; S Morino; E Bucci; N Accornero
Journal: J Neurol Neurosurg Psychiatry Date: 2003-07 Impact factor: 10.154

9. Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases.

Authors: Mario-Ubaldo Manto; Marie-Aline Laute; Michèle Aguera; Véronique Rogemond; Massimo Pandolfo; Jérome Honnorat
Journal: Ann Neurol Date: 2007-06 Impact factor: 10.422

10. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.

Authors: J Kim; M Namchuk; T Bugawan; Q Fu; M Jaffe; Y Shi; H J Aanstoot; C W Turck; H Erlich; V Lennon; S Baekkeskov
Journal: J Exp Med Date: 1994-08-01 Impact factor: 14.307

4 in total

1. Autoimmune epilepsy: clinical characteristics and response to immunotherapy.

Authors: Amy M L Quek; Jeffrey W Britton; Andrew McKeon; Elson So; Vanda A Lennon; Cheolsu Shin; Christopher Klein; Robert E Watson; Amy L Kotsenas; Terrence D Lagerlund; Gregory D Cascino; Gregory A Worrell; Elaine C Wirrell; Katherine C Nickels; Allen J Aksamit; Katherine H Noe; Sean J Pittock
Journal: Arch Neurol Date: 2012-05